Vivet will be attending and presenting at the EPA World Congress in Amsterdam – March 21-23, 2023.

➡️ https://www.terrapinn.com/conference/pharma-pricing/agenda.stm

Thomas Daniel-Robin, Vivet Therapeutic’s BD Director, will take part in the HTA session and give the following presentation: “Healthcare databases versus current practice – gaps in information for patients, payers and physicians in Wilson Disease” (March 21, 4.25-5.30pm CET).

Topics to be discussed on the potential of national healthcare databases will include:

👉 Generating Real World Data for Rare Diseases: large cohorts and long-term follow-up

👉 Identifying data gaps between Real World Data and current practice: what can and cannot be captured by physicians and patients

👉 Finding the unexpected and understanding the value of enriched studies